Supply chain issues are making it tough for many people to get their estrogen patches. Take Motter, for example. She easily picked up her first prescription in August, but when she needed a refill, her local pharmacy was out of stock. She ended up driving an hour to find what she needed, only to switch brands multiple times since then.
“It’s stressful to find something that works and then worry about whether you can get it again,” she shared.
Dr. Anna Groysman, an endocrinologist at Penn Medicine, sees patients grappling with these shortages regularly. “We’re often on the phone calling pharmacies, trying to help our patients find alternatives,” she said.
Some patients may switch to other forms of estrogen therapy, like oral pills or gels. But these alternatives aren’t always straightforward. Patients may need to try several options to find what’s right for them. “It can take six to eight weeks to see if a new dose works,” Groysman explained. “That’s a long time to wait.”
Switching treatments can also come with risks. For instance, oral pills may pose higher chances of blood clots or strokes. Insurers might not cover gels, making them an expensive choice. Plus, patients may need new prescriptions and prior approval from their insurance, adding more hurdles.
“We’re putting them through unnecessary trouble,” Groysman said.
Experts recommend that patients work closely with their menopause healthcare providers to navigate these challenges. Healthcare provider Jordan advises submitting refill requests early, so there’s time to deal with any potential supply issues. “We need to make it easier for women,” she emphasized. “It shouldn’t be this hard.”
Statistics show that over 60% of patients on hormone replacement therapy face medication access issues due to supply chain disruptions. This has sparked discussions on social media about alternative treatments and personal experiences, reflecting a shared concern among many. As these issues persist, it highlights the need for better systems in place to support those relying on hormone therapy.
We can learn from this situation by understanding the importance of reliable medication access. Addressing these ongoing issues can significantly improve quality of life for many individuals. For more details on the current state of hormonal therapy access, you can check out this [report by the National Institutes of Health](https://www.nih.gov/news-events/news-releases/hormone-therapy-access-patients-impacted-supply-chain-issues).
Source link
menopause,women
